生物技术通报 ›› 2015, Vol. 31 ›› Issue (10): 216-221.doi: 10.13560/j.cnki.biotech.bull.1985.2015.10.033

• 研究报告 • 上一篇    下一篇

重组人纤溶酶原激活剂转基因兔的制备及其表达产物的检测

陆睿,宋绍征,祁正强,葛欣,邵宾,成勇   

  1. 江苏省转基因动物制药工程研究中心, 扬州 225009
  • 收稿日期:2015-01-19 出版日期:2015-10-28 发布日期:2015-10-28
  • 作者简介:陆睿, 男, 硕士, 研究方向:动物转基因与生物制药; E-mail:halurui@163.com
  • 基金资助:
    国家转基因生物新品种培育重大专项(2014ZX08008-004), 江苏省科技支撑项目(BE2013679), 江苏省优势学科建设工程资助项目, 大学研究生科研创新项目(CXLX-1435), 扬州大学研究生科研创新项目(CXLX-1435)

Preparation of Recombinant Human Plasminogen Activator in Rabbit Mammary Gland and Detection of Expressed Products

Lu Rui, Song Shaozheng, Qi Zhengqiang, Ge Xin, Shao Bin, Cheng Yong   

  1. Engineering Research Centre for Transgenic Animal Pharming of Jiangsu Province, Yangzhou 225009
  • Received:2015-01-19 Published:2015-10-28 Online:2015-10-28

摘要: 人组织纤溶酶原激活剂(ht-PA)是临床血栓疾病治疗的主要生物药品, 应用转基因动物乳腺生物反应器制备已有报道, 但重组人纤溶酶原激活剂(rhPA)在转基因动物中表达尚未见报道。设计了以人t-PA的F、E、K1区位点缺失体为编码序列, 以山羊β-酪蛋白/CMV杂合启动/增强子, 构建了乳腺特异性表达载体PCL25/rhPA, 通过受精卵原核显微注射法制备转基因兔。用PCR检测及其产物测序筛选转基因兔, ELISA试剂盒及纤维蛋白平板溶圈法检测转基因兔的表达产物。实验获得原代转基因兔5只(2♂, 3♀), 其中2只乳腺中表达人重组纤溶酶原激活剂, rhPA浓度最高可达400 μg/mL, 表达产物比活性是现有阿替普酶的150-200倍。实验结果表明, 重组人纤溶酶原激活剂(rhPA)可以在山羊β-酪蛋白/CMV杂合启动/增强子调控下获得乳腺特异性表达, 表达重组蛋白具有较高的溶栓活性。

关键词: 转基因兔, 人组织纤溶酶原激活剂(ht-PA), 乳腺特异性表达

Abstract: Human tissue-type plasminogen activator(ht-PA)is a major biomedicine used in the clinical treatment of thrombotic diseases. There have been some reports on transgenic animal mammary gland as bioreactor producing ht-PA, however, there has been no report about recombinant human-tissue plasminogen activator(rhPA)expressed in transgenic animals. Here we report the preparation of transgenic rabbits by microinjection of fertilized eggs with the constructed mammary gland-specifically expressed vector of PCL25/rhPA while using F, E, and K1 loci deletants of human t-PA as coding sequence driven by the goat beta-casein/CMV chimeric promoter. PCR and sequencing PCR products were used to identify the transgenic rabbits from candidates, and ELISA and fibrin agarose plate assay(FAPA)to analyze the expressed products of the transgenic rabbits. Results showed that 5 rabbits(2♂, 3♀)were transgenic rabbits and rhPA were expressed in their milk of 2 rabbits with maximum content of 400 μg/mL, and its biological activity was 150-200 times of alteplase. This study implies that rhPA can be expressed specifically in the mammary glands under the regulation of goat beta-casein/CMV chimeric promoter, and the expressed recombinant protein possesses the high activity of thrombolysis.

Key words: transgene rabbit, human tissue-type plasminogen activator(ht-PA), mammary gland-specifically expression